Match tier Confirmed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-05

Supriya Peshin

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Fellow

Also affiliated: University of Southern California (2019); East Tennessee State University (2022–2024); Brooklyn Hospital Center (2024); Monmouth Medical Center (2024); The University of Texas MD Anderson Cancer Center (2024); University of Kentucky (2024); Cancer Council Queensland (2025); Massachusetts General Hospital (2025); Trinity Health Oakland Hospital (2024); Einstein Healthcare Network (2024); Ballad Health (2024–2026); Norton Community Hospital (2024–2026); Cleveland Clinic Abu Dhabi (2025); University of Pennsylvania (2022)

9 h-index 115 pubs 219 cited

  • Humans
  • Molecular Targeted Therapy
  • Antineoplastic Agents
  • Lung Neoplasms
  • Circulating Tumor DNA
  • Receptors, Chimeric Antigen
  • T-Lymphocytes
  • Immunotherapy, Adoptive
  • Female
  • Male
  • Bile Duct Neoplasms
  • Biomarkers, Tumor
  • Cholangiocarcinoma
  • Combined Modality Therapy
  • Immunotherapy

Biography and Research Information

OverviewAI-generated summary

Supriya Peshin's research focuses on advancing the understanding and treatment of various cancers, including non-small-cell lung cancer, pancreatic cancer, and intrahepatic cholangiocarcinoma. Peshin's work investigates current therapeutic strategies and emerging treatments, emphasizing molecular testing and targeted therapies. Their research also explores the role of circulating tumor DNA in cancer management and the development of novel assays for detecting chimeric antigen receptors. Additionally, Peshin has contributed to reviews on the management of hypertrophic cardiomyopathy and lifestyle medicine in cancer survivorship. With a publication record of 109 papers and an h-index of 9, Peshin is an active contributor to the medical research community.

Metrics

  • h-index: 9
  • Publications: 115
  • Citations: 219

Positions

  • Fellow
    University of Arkansas System Internal Medicine ORCID
  • Fellow publications 2026
    University of Arkansas for Medical Sciences ORCID

Selected Publications

  • Small Cell Lung Cancer in Transition: Recent Advances in Biology, Treatment, and Precision Medicine (2026)
    Cancers DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

9 Collaborators 6 Institutions 4 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics